Susquehanna International Group
SVNT

Susquehanna International Group’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Susquehanna International Group’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-120,673
Closed -$75K – 9760
2013
Q3 		$75K Buy
120,673
+1,104
+0.9% +$706 ﹤0.01% 8167
2013
Q2 		$67K Buy
+119,569
New +$83.3K ﹤0.01% 7908

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Susquehanna International Group's SVNT Position: Q4 2013 in Review

Susquehanna International Group sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 120,673 shares — an estimated $75K sold.

Susquehanna International Group first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $75K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Susquehanna International Group reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Susquehanna International Group sold 120,673 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $75K.
  • Susquehanna International Group first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Susquehanna International Group's SAVIENT PHARMACEUTICALS INC position peaked at $75K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Susquehanna International Group's 13F filing for Q4 2013, filed 13 Feb 2014.